Cargando…

Recruitment methods and yield rates for a multisite clinical trial exploring risk reduction for Alzheimer's disease (rrAD)

INTRODUCTION: The risk reduction for Alzheimer's disease (rrAD) trial was a multisite clinical trial to assess exercise and intensive vascular pharmacological treatment on cognitive function in community‐dwelling older adults at increased risk for Alzheimer's disease. METHODS: Eligibility,...

Descripción completa

Detalles Bibliográficos
Autores principales: Szabo‐Reed, Amanda N., Hall, Tristyn, Vidoni, Eric D., Van Sciver, Angela, Sewell, Monica, Burns, Jeffrey M., Cullum, C. Munro, Gahan, William P., Hynan, Linda S., Kerwin, Diana R., Rossetti, Heidi, Stowe, Ann M., Vongpatanasin, Wanpen, Zhu, David C., Zhang, Rong, Keller, Jeffrey N., Binder, Ellen F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576444/
https://www.ncbi.nlm.nih.gov/pubmed/37841653
http://dx.doi.org/10.1002/trc2.12422
_version_ 1785121123184148480
author Szabo‐Reed, Amanda N.
Hall, Tristyn
Vidoni, Eric D.
Van Sciver, Angela
Sewell, Monica
Burns, Jeffrey M.
Cullum, C. Munro
Gahan, William P.
Hynan, Linda S.
Kerwin, Diana R.
Rossetti, Heidi
Stowe, Ann M.
Vongpatanasin, Wanpen
Zhu, David C.
Zhang, Rong
Keller, Jeffrey N.
Binder, Ellen F.
author_facet Szabo‐Reed, Amanda N.
Hall, Tristyn
Vidoni, Eric D.
Van Sciver, Angela
Sewell, Monica
Burns, Jeffrey M.
Cullum, C. Munro
Gahan, William P.
Hynan, Linda S.
Kerwin, Diana R.
Rossetti, Heidi
Stowe, Ann M.
Vongpatanasin, Wanpen
Zhu, David C.
Zhang, Rong
Keller, Jeffrey N.
Binder, Ellen F.
author_sort Szabo‐Reed, Amanda N.
collection PubMed
description INTRODUCTION: The risk reduction for Alzheimer's disease (rrAD) trial was a multisite clinical trial to assess exercise and intensive vascular pharmacological treatment on cognitive function in community‐dwelling older adults at increased risk for Alzheimer's disease. METHODS: Eligibility, consent, and randomization rates across different referral sources were compared. Informal interviews conducted with each site's project team were conducted upon study completion. RESULTS: Initially, 3290 individuals were screened, of whom 28% were eligible to consent, 805 consented to participate (87.2% of those eligible), and 513 (36.3% of those consented) were randomized. Emails sent from study site listservs/databases yielded the highest amount (20.9%) of screened individuals. Professional referrals from physicians yielded the greatest percentage of consented individuals (57.1%). Referrals from non‐professional contacts (ie, friends, family; 75%) and mail/phone contact from a site (73.8%) had the highest yield of randomization. DISCUSSION: Professional referrals or email from listservs/registries were most effective for enrolling participants. The greatest yield of eligible/randomized participants came from non‐professional and mail/phone contacts. Future trials should consider special efforts targeting these recruitment approaches. HIGHLIGHTS: Clinical trial recruitment is commonly cited as a significant barrier to advancing our understanding of cognitive health interventions. The most cited referral source was email, followed by interviews/editorials on the radio, television, local newspapers, newsletters, or magazine articles. The referral method that brought in the largest number of contacts was email but did not result in the greatest yield of consents or eligible participants. The sources that yielded the greatest likelihood of consent were professional referrals (ie, physician), social media, and mail/phone contact from study site. The greatest yield of eligible/randomized participants came from non‐professional contacts and mail/phone contact from a site. Findings suggest that sites may need to focus on more selective referral sources, such as using contact mailing and phone lists, rather than more widely viewed recruitment sources, such as social media or TV/radio advertisements.
format Online
Article
Text
id pubmed-10576444
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-105764442023-10-15 Recruitment methods and yield rates for a multisite clinical trial exploring risk reduction for Alzheimer's disease (rrAD) Szabo‐Reed, Amanda N. Hall, Tristyn Vidoni, Eric D. Van Sciver, Angela Sewell, Monica Burns, Jeffrey M. Cullum, C. Munro Gahan, William P. Hynan, Linda S. Kerwin, Diana R. Rossetti, Heidi Stowe, Ann M. Vongpatanasin, Wanpen Zhu, David C. Zhang, Rong Keller, Jeffrey N. Binder, Ellen F. Alzheimers Dement (N Y) Research Articles INTRODUCTION: The risk reduction for Alzheimer's disease (rrAD) trial was a multisite clinical trial to assess exercise and intensive vascular pharmacological treatment on cognitive function in community‐dwelling older adults at increased risk for Alzheimer's disease. METHODS: Eligibility, consent, and randomization rates across different referral sources were compared. Informal interviews conducted with each site's project team were conducted upon study completion. RESULTS: Initially, 3290 individuals were screened, of whom 28% were eligible to consent, 805 consented to participate (87.2% of those eligible), and 513 (36.3% of those consented) were randomized. Emails sent from study site listservs/databases yielded the highest amount (20.9%) of screened individuals. Professional referrals from physicians yielded the greatest percentage of consented individuals (57.1%). Referrals from non‐professional contacts (ie, friends, family; 75%) and mail/phone contact from a site (73.8%) had the highest yield of randomization. DISCUSSION: Professional referrals or email from listservs/registries were most effective for enrolling participants. The greatest yield of eligible/randomized participants came from non‐professional and mail/phone contacts. Future trials should consider special efforts targeting these recruitment approaches. HIGHLIGHTS: Clinical trial recruitment is commonly cited as a significant barrier to advancing our understanding of cognitive health interventions. The most cited referral source was email, followed by interviews/editorials on the radio, television, local newspapers, newsletters, or magazine articles. The referral method that brought in the largest number of contacts was email but did not result in the greatest yield of consents or eligible participants. The sources that yielded the greatest likelihood of consent were professional referrals (ie, physician), social media, and mail/phone contact from study site. The greatest yield of eligible/randomized participants came from non‐professional contacts and mail/phone contact from a site. Findings suggest that sites may need to focus on more selective referral sources, such as using contact mailing and phone lists, rather than more widely viewed recruitment sources, such as social media or TV/radio advertisements. John Wiley and Sons Inc. 2023-10-14 /pmc/articles/PMC10576444/ /pubmed/37841653 http://dx.doi.org/10.1002/trc2.12422 Text en © 2023 The Authors. Alzheimer's & Dementia: Translational Research & Clinical Interventions published by Wiley Periodicals LLC on behalf of Alzheimer's Association. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Research Articles
Szabo‐Reed, Amanda N.
Hall, Tristyn
Vidoni, Eric D.
Van Sciver, Angela
Sewell, Monica
Burns, Jeffrey M.
Cullum, C. Munro
Gahan, William P.
Hynan, Linda S.
Kerwin, Diana R.
Rossetti, Heidi
Stowe, Ann M.
Vongpatanasin, Wanpen
Zhu, David C.
Zhang, Rong
Keller, Jeffrey N.
Binder, Ellen F.
Recruitment methods and yield rates for a multisite clinical trial exploring risk reduction for Alzheimer's disease (rrAD)
title Recruitment methods and yield rates for a multisite clinical trial exploring risk reduction for Alzheimer's disease (rrAD)
title_full Recruitment methods and yield rates for a multisite clinical trial exploring risk reduction for Alzheimer's disease (rrAD)
title_fullStr Recruitment methods and yield rates for a multisite clinical trial exploring risk reduction for Alzheimer's disease (rrAD)
title_full_unstemmed Recruitment methods and yield rates for a multisite clinical trial exploring risk reduction for Alzheimer's disease (rrAD)
title_short Recruitment methods and yield rates for a multisite clinical trial exploring risk reduction for Alzheimer's disease (rrAD)
title_sort recruitment methods and yield rates for a multisite clinical trial exploring risk reduction for alzheimer's disease (rrad)
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576444/
https://www.ncbi.nlm.nih.gov/pubmed/37841653
http://dx.doi.org/10.1002/trc2.12422
work_keys_str_mv AT szaboreedamandan recruitmentmethodsandyieldratesforamultisiteclinicaltrialexploringriskreductionforalzheimersdiseaserrad
AT halltristyn recruitmentmethodsandyieldratesforamultisiteclinicaltrialexploringriskreductionforalzheimersdiseaserrad
AT vidoniericd recruitmentmethodsandyieldratesforamultisiteclinicaltrialexploringriskreductionforalzheimersdiseaserrad
AT vansciverangela recruitmentmethodsandyieldratesforamultisiteclinicaltrialexploringriskreductionforalzheimersdiseaserrad
AT sewellmonica recruitmentmethodsandyieldratesforamultisiteclinicaltrialexploringriskreductionforalzheimersdiseaserrad
AT burnsjeffreym recruitmentmethodsandyieldratesforamultisiteclinicaltrialexploringriskreductionforalzheimersdiseaserrad
AT cullumcmunro recruitmentmethodsandyieldratesforamultisiteclinicaltrialexploringriskreductionforalzheimersdiseaserrad
AT gahanwilliamp recruitmentmethodsandyieldratesforamultisiteclinicaltrialexploringriskreductionforalzheimersdiseaserrad
AT hynanlindas recruitmentmethodsandyieldratesforamultisiteclinicaltrialexploringriskreductionforalzheimersdiseaserrad
AT kerwindianar recruitmentmethodsandyieldratesforamultisiteclinicaltrialexploringriskreductionforalzheimersdiseaserrad
AT rossettiheidi recruitmentmethodsandyieldratesforamultisiteclinicaltrialexploringriskreductionforalzheimersdiseaserrad
AT stoweannm recruitmentmethodsandyieldratesforamultisiteclinicaltrialexploringriskreductionforalzheimersdiseaserrad
AT vongpatanasinwanpen recruitmentmethodsandyieldratesforamultisiteclinicaltrialexploringriskreductionforalzheimersdiseaserrad
AT zhudavidc recruitmentmethodsandyieldratesforamultisiteclinicaltrialexploringriskreductionforalzheimersdiseaserrad
AT zhangrong recruitmentmethodsandyieldratesforamultisiteclinicaltrialexploringriskreductionforalzheimersdiseaserrad
AT kellerjeffreyn recruitmentmethodsandyieldratesforamultisiteclinicaltrialexploringriskreductionforalzheimersdiseaserrad
AT binderellenf recruitmentmethodsandyieldratesforamultisiteclinicaltrialexploringriskreductionforalzheimersdiseaserrad